Figure 1From: Intracardiac injection of a capsid-modified Ad5/35 results in decreased heart toxicity when compared to standard Ad5CD46 expression in the heart. A-B show heart tissue of hCD46ge transgenic mice and C-D human heart tissue. Panels A and C show positive anti-human CD46 receptor immunostaining on cell surfaces. Panels B and D are isotype controls showing the level of background signal. The scale bar represents 100 μm.Back to article page